MedPath
NMPA Approval

Gilteritinib Fumarate Tablets

国药准字HJ20210009

January 30, 2021

Drug Information

富马酸吉瑞替尼片

适加坦

片剂

40mg(按C29H44N8O3计)

化学药品

January 30, 2021

January 29, 2026

Company Information

Applicant Company

5-1,Nihonbashi-Honcho 2-chome,Chuo-ku,Tokyo 103-8411,Japan

Manufacturing Company

astellas pharma inc. yaizu technology center

180 Ozumi,Yaizu-shi,Shizuoka 425-0072,Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

富马酸吉瑞替尼片 - NMPA 批准文号 | MedPath